武汉费斯德生物科技有限公司, NewEast Biosciences 中国办事处
武汉费斯德生物科技有限公司是美国NewEast Biosciences在中国的办事处。NewEast Biosciences 在十二年前率先研发俩种独特的抗体。这俩种抗体仅仅识别活性的GTP酶或者突变的Oncogene。 GTP酶涉及(1)响应细胞表面受体激活的信号转导,包括跨膜受体,例如介导味觉、嗅觉和视觉的那些,(2)核糖体的蛋白质生物合成,(3)调节细胞分化、增殖、分裂和运动,(4)蛋白质通过膜的易位,(5)细胞内囊泡的运输,以及囊泡介导的分泌和摄取,通过GTP酶控制囊泡外壳组装。Oncogene侧是诱发癌症的基因。
我公司将向你提供以下的独一无二的三种抗体或者试剂盒: (1) 仅识别 GTP酶的活性构型的产品, 它可以让你能够量化GTP酶在细胞中的活性和分布。(2) 识别突变 Oncogene蛋白, 但不认识相应野生型的抗体。 (3) 对 cAMP 和 cGMP 具有超亲和力(无需乙酰化)ELISA检测试剂盒。这些产品被将近一千篇同行评议的文章所引用。
¥2,850.00
货号: S220516 | ||||
产品全名: EID3 兔多抗 | ||||
基因符号 NS4EB; NSE4B; NSMCE4B | ||||
UNIPROT ID: Q8N140 (Gene Accession – NP_001008395 ) | ||||
背景: EID3 is highly expressed in testis and shows homology to a region of EID1 implicated in binding to CBP/p300. EID3 acts as a potent inhibitor of nuclear receptor transcriptional activity by a mechanism that is independent of direct interactions with nuclear receptors, including SHP. Furthermore, EID3 directly binds to and blocks the SRC-1 interacting domain of CBP, which has been implicated to act as the interaction surface for nuclear receptor co-activators. Consistent with this idea, EID3 prevents recruitment of CBP to a natural nuclear receptor-regulated promoter. | ||||
抗原: Synthetic peptide of human EID3 | ||||
经过测试的应用: ELISA, IHC | ||||
推荐稀释比: IHC: 25-100; ELISA: 1000-2000 | ||||
种属反应性: Rabbit | ||||
克隆性: Rabbit Polyclonal | ||||
亚型: Immunogen-specific rabbit IgG | ||||
纯化: Antigen affinity purification | ||||
种属反应性: Human | ||||
成分: PBS (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.05% Sodium Azide and 40% glycerol | ||||
研究领域: Signal Transduction, Epigenetics and Nuclear Signaling, Cancer | ||||
储存和运输: Store at -20°C. Avoid repeated freezing and thawing | ||||
|